|
发表于 2011-3-1 16:00:10
|
显示全部楼层
Oropharyngeal decontamination in intensive care patients:less is not more
Ventilator-associated pneumonia (VAP) is a common cause of morbidity, antibiotic use, increased length of stay and, possibly,increased mortality in ICU patients. Colonization of the oropharyngeal cavity with potentially pathogenic micro-organisms is instrumental in the pathogenesis of VAP, and selective oropharyngeal decontamination (SOD) with antibiotics (AB-SOD) or antiseptics,such as chlorhexidine gluconate (CHX-SOD), has been associated with reduced incidences of VAP. In a recent issue of Critical Care Scannapieco and colleagues investigated differences in oropharyngeal colonization between mechanically ventilated patients receiving oropharyngeal decontamination with 0.12% CHX-SOD either once or twice daily compared to placebo. CHX-SOD was associated with a reduction in Staphylococcus aureus colonization,but the study was underpowered to demonstrate a reduction in VAP incidence. We urgently need well-designed and adequately powered studies to evaluate the potential benefits of CHX-SOD on patient outcome in ICUs.
SDD--预防VAP.pdf
2011-4-24 22:55 上传
点击文件名下载附件
下载积分: 金币 -2 金
43.35 KB, 下载次数: 12, 下载积分: 金币 -2 金
[h2]评分[/h2]
参与人数 1 +10
收起
理由
星火
+ 10
精品文章
查看全部评分
|
|